| HOME >> BIOLOGY >> TECHNOLOGY |
Selling expenses 363,131 521,608
Research and development 177,773 119,719
Depreciation and amortization 129,298 172,011
Allowance and provision 588 220,148
Total operating expenses 2,652,600 2,490,239
Operating loss (2,126,616) (2,309,943)
Interest expenses (766,411) (231,559)
Loss before minority interest in a
subsidiary's deficit (2,893,027) (2,541,502)
Minority interest in a subsidiary's
deficit (332) 19,356
Net loss from continuing operation (2,893,359) (2,522,146)
Loss from discontinued operations
Net income (loss) - Urea
Entrepot Trade (414,509) 238,047
Net loss (3,307,868) (2,284,099)
Other comprehensive loss:
Translation adjustment (61,111) (95,776)
Comprehensive loss $ (3,368,979) $ (2,379,875)
Net profit (loss) from continuing
operations per common share
- - basic and diluted $ (0.038) $ (0.040)
Net profit (loss) on discontinued
operations per common share
- - basic and diluted $ (0.005) $
0.004
Weighted average number of common
shares outstanding-basic and
diluted 75,543,446 63,646,482
CONSOLIDATED BALANCE SHEETS (AUDITED)
December 31, December 31,
'/>"/>
| SOURCE Kiwa Bio-Tech Products Group Corporation Copyright©2008 PR Newswire. All rights reserved |